{"status": "ok", "totalResults": 7, "articles": [{"source": {"id": null, "name": "CoinDesk"}, "author": "Sam Reynolds", "title": "Hong Kong Bitcoin and Ether ETFs Have Soft Debut - CoinDesk", "description": "The volume of crypto exchange-traded funds came in at just over $11 million.", "url": "https://www.coindesk.com/markets/2024/04/30/hong-kong-bitcoin-and-ether-etfs-have-soft-debut/", "urlToImage": "https://www.coindesk.com/resizer/AcbVcB4hgSK5T8oWVJtTuXPTnws=/1200x628/center/middle/cloudfront-us-east-1.images.arcpublishing.com/coindesk/YJKVVHZBQ5FXTPRG3VLYIHZ3JQ.jpg", "publishedAt": "2024-04-30T08:50:00Z", "content": "Please note that ourprivacy policy,terms of use,cookies, anddo not sell my personal informationhas been updated.\r\nCoinDesk is anaward-winningmedia outlet that covers the cryptocurrency industry. Its \u2026 [+593 chars]"}, {"source": {"id": null, "name": "Ses.com"}, "author": null, "title": "SES to acquire Intelsat in compelling transaction focused on the future - SES | Satellite", "description": "Value accretive transaction underpinned by \u20ac2.4 billion (NPV) of readily executable synergies.", "url": "https://www.ses.com/press-release/ses-acquire-intelsat-compelling-transaction-focused-future", "urlToImage": null, "publishedAt": "2024-04-30T03:06:22Z", "content": "<ul><li>Value accretive transaction underpinned by 2.4 billion (NPV) of readily executable synergies.</li><li>Creating a stronger multi-orbit operator with ~60% of revenue in high growth segments.</l\u2026 [+17011 chars]"}, {"source": {"id": null, "name": "BBC News"}, "author": null, "title": "Migrants hit by high fees to send money home - BBC.com", "description": "Sending money across borders, particularly in Africa, can still be expensive.", "url": "https://www.bbc.com/news/business-68817110", "urlToImage": "https://ichef.bbci.co.uk/news/1024/branded_news/15021/production/_133194068_jerrylukendombokani.creditrelon..jpg", "publishedAt": "2024-04-29T23:42:30Z", "content": null}, {"source": {"id": null, "name": "[Removed]"}, "author": null, "title": "[Removed]", "description": "[Removed]", "url": "https://removed.com", "urlToImage": null, "publishedAt": "1970-01-01T00:00:00Z", "content": "[Removed]"}, {"source": {"id": null, "name": "ForexLive"}, "author": "Adam Button", "title": "USD/JPY dip buyers wade in again - ForexLive", "description": "USD/JPY 5 mins There's no official confirmation that Japan's ministry of finance intervened today but there are certainly tell-tale signs.", "url": "https://www.forexlive.com/news/usdjpy-dip-buyers-wade-in-again-20240429/", "urlToImage": "https://images.forexlive.com/images/USDJPY%205%20mins_id_40ed1030-b723-4a78-8ee4-38244ebcdcdb_size975.jpg", "publishedAt": "2024-04-29T17:52:00Z", "content": "High risk warning:\r\nForeign exchange trading carries a high level of risk that may not be suitable for all investors. Leverage creates additional risk and loss exposure. Before you decide to trade fo\u2026 [+2129 chars]"}, {"source": {"id": "reuters", "name": "Reuters"}, "author": "Howard Schneider", "title": "Fed in holding pattern as inflation delays approach to soft landing - Reuters", "description": "Inflation showing no recent sign of slowing or narrowing in scope leaves U.S. Federal Reserve policymakers challenged this week over how to characterize their next steps even as the countdown to a contentious U.S. presidential election continues.", "url": "https://www.reuters.com/markets/us/fed-holding-pattern-inflation-delays-approach-any-soft-landing-2024-04-29/", "urlToImage": "https://www.reuters.com/resizer/v2/LPDXIDJ57FIAZPYHO5Q3AO4EXI.jpg?auth=2c97c050e5a8ad425e0f478ca7dd1cc0e762fda9f74ba667ddd3e7c7be5171a0&height=1005&width=1920&quality=80&smart=true", "publishedAt": "2024-04-29T10:10:00Z", "content": null}, {"source": {"id": null, "name": "Astrazeneca.com"}, "author": null, "title": "Enhertu demonstrated statistically significant and clinically meaningful improvement in progression-free survival in HR-positive, HER2-low metastatic breast cancer following one or more lines of endocrine therapy in DESTINY-Breast06 Phase III trial - AstraZeneca", "description": "", "url": "https://www.astrazeneca.com/media-centre/press-releases/2024/enhertu-improved-pfs-in-her2-low-and-ultralow.html", "urlToImage": "", "publishedAt": "2024-04-29T01:30:00Z", "content": "Positive high-level results from the DESTINY-Breast06 Phase III trial showed that Enhertu (trastuzumab deruxtecan) demonstrated a statistically significant and clinically meaningful improvement in pr\u2026 [+12518 chars]"}]}